Oncoscience

Oncoscience is a biopharmaceutical company that provides products for the treatment of orphan indications in oncology. It is engaged in the development of Nimotuzumab, a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and can be used for the treatment of several malignancies.
TypeSubsidiary
HQSchenefeld, DE
Founded2001
Websiteoncoscience.de
Cybersecurity ratingAMore
Oncoscience was founded in 2001 and is headquartered in Schenefeld, DE

Viewing summary data as a guest

Sign up for free to see all data

Oncoscience Office Locations

Oncoscience has an office in Schenefeld
Schenefeld, DE (HQ)
Osterbrooksweg 57/59
Show all (1)

Oncoscience Financials and Metrics

Summary Metrics

Founding Date

2001

Oncoscience Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Oncoscience Online and Social Media Presence

Embed Graph

Oncoscience Blogs

Specific Pharma A/S and Oncoscience GmbH launch a Named Patient Program for the treatment of cancer with nimotuzumab.

Specific Pharma announced today that it has entered into a supply and distribution collaboration with German based Oncoscience GmbH regarding the distribution of CIMAher® (nimotuzumab) in the Nordics. Specific Pharma will distribute CIMAher® in Denmark, Sweden, Finland, Norway and Iceland on a named…

Oncoscience Frequently Asked Questions

  • When was Oncoscience founded?

    Oncoscience was founded in 2001.

  • How many employees does Oncoscience have?

    Oncoscience has 2 employees.

  • Who are Oncoscience competitors?

    Competitors of Oncoscience include Xilio Therapeutics, Rakuten Medical and Sareum Holdings.

  • Where is Oncoscience headquarters?

    Oncoscience headquarters is located at Osterbrooksweg 57/59, Schenefeld.

  • Where are Oncoscience offices?

    Oncoscience has an office in Schenefeld.

  • How many offices does Oncoscience have?

    Oncoscience has 1 office.